QR-Code

Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials

Abstract Background Patients with episodic migraine (EM) with a higher-frequency of migraine headache days (HFEM: 8–14 migraine headache days/month) have a greater disease burden and a higher risk of progressing to chronic migraine (CM) with associated acute treatment overuse versus those with low-f...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: Jakub Jedynak, Eric Eross, Astrid Gendolla, Mallikarjuna Rettiganti, Virginia L. Stauffer
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2021-05-01
Schriftenreihe:The Journal of Headache and Pain
Schlagworte:
Online-Zugang:https://doi.org/10.1186/s10194-021-01222-w
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!